Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Kaposi Sarcoma: early-phase trial registry
11 of 14 indexed Kaposi Sarcoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 11 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Kaposi Sarcoma: 14 US clinical trials tracked, 11 recruiting.
Kaposi Sarcoma is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is National Cancer Institute (NCI), running 7 of these trials.
Enrollment posture brief
Registry condition kaposi-sarcoma
OPEN 11 | RECR 79% | LATE 0 | EARLY 9 | RANK #1230 | SPON 7
Volume-matched condition peers
Nearest open-share peer: Obesity Prevention (79% recruiting · 14 trials)
Kaposi Sarcoma lists 11 open slots (79% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Kaposi Sarcoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Kaposi Sarcoma is recruiting above its size-band peers.
11 of 14 indexed trials (78.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Kaposi Sarcoma research.
National Cancer Institute (NCI) accounts for 7 of 14 trials (50%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Kaposi Sarcoma trials plan to enrol fewer than 100 people.
Median target enrolment is 62 among the 14 trials that report a genuine target (sentinel values excluded). 11 of those (78.6%) plan for fewer than 100 participants.
-
Kaposi Sarcoma splits between interventional and observational designs.
9 interventional and 5 observational studies make up this index (64.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
AIDS Malignancy Consortium
NCT05663502
Natural History Study of Kaposi Sarcoma
National Cancer Institute (NCI)
NCT06375122
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
National Cancer Institute (NCI)
NCT04941274
PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
National Cancer Institute (NCI)
NCT04303117
A Study of sEphB4-HSA in Kaposi Sarcoma
Vasgene Therapeutics
NCT03993106
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
National Cancer Institute (NCI)
NCT04902443
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Memorial Sloan Kettering Cancer Center
NCT05859074
Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)
National Cancer Institute (NCI)
NCT07308886
Trial of Ixazomib for Kaposi Sarcoma
AIDS Malignancy Consortium
NCT04305691
Propranolol for the Treatment of Kaposi Sarcoma in Adults
Washington University School of Medicine
NCT06445166
Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial
Washington University School of Medicine
NCT06751355
Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
National Cancer Institute (NCI)
NCT02659930
Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
National Cancer Institute (NCI)
NCT04742387
Development of Serologic Assays for Human Herpes Virus-8
National Institutes of Health Clinical Center (CC)
NCT00395278
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Kaposi Sarcoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Kaposi Sarcoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Kaposi Sarcoma page
14 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 11 Kaposi Sarcoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Cancer Institute (NCI) sponsors the most Kaposi Sarcoma trials on record, review their full trial history before evaluating a specific study. See National Cancer Institute (NCI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kaposi Sarcoma condition card totals 14 registered trials; most-linked intervention pomalidomide; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.